Press releases

JERSEY, Channel Islands, May 12, 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that it will host a key opinion leader (KOL) webinar on the current landscape and unmet needs within blood grouping and

New York Blood Center, Inc. and Centro de Transfusiones de la Comunidad de Madrid join MosaiQ’s Innovator’s Circle in partnership to improve patient care and laboratory efficiencies JERSEY, Channel Islands, 21 March 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a

The Extended Immunohematology microarray provides labs with comprehensive characterization, simplified workflow, and high throughput—all on a single multimodal multiplexing platform   JERSEY, Channel Islands, 8 March 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered

MosaiQ virtual Scientific Advisory Board (SAB) was attended this week by eight Key Opinion Leaders (KOLs) from the US and various European countries Quotient’s focus is to strengthen MosaiQ scientific and medical evidence through the Innovator’s Circle and Investigator Initiated

Received feedback from the European notified body after review of Expanded IH submission Pleased with feedback and expect to submit a response to the questions in the next couple of weeks Continue to expect approval in Q1 CY 2022  

“It is my pleasure to welcome Esteban to the Executive team at this exciting time in our Company’s evolution. Esteban brings his experience in leading high-growth teams and unifying manufacturing and supply chain management. As we transition the company from